Basic Information
| RNALocate ID: | RLID-D:11001354 |
| RNA Symbol: | hsa-miR-590-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-590-5p |
| RNA ID: | miRBase:MIMAT0003258 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002446 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002447 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002448 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002449 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11003278 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003279 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003280 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000523 | Microvesicle | Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-590-5p | Cardiomyopathies | MNDR-E-MI-62227 |
| MNDR | hsa-miR-590-5p | Oral squamous cell carcinoma | MNDR-E-MI-62228 |
| MNDR | hsa-miR-590-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-62229 |
| MNDR | hsa-miR-590-5p | Lymphoma | MNDR-E-MI-62230 |
| MNDR | hsa-miR-590-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-62231 |
| MNDR | hsa-miR-590-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-62232 |
| MNDR | hsa-miR-590-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-62233 |
| MNDR | hsa-miR-590-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-62234 |
| MNDR | hsa-miR-590-5p | Her2-receptor positive breast cancer | MNDR-E-MI-62235 |
| MNDR | hsa-miR-590-5p | Breast cancer luminal | MNDR-E-MI-62236 |
| MNDR | hsa-miR-590-5p | Myeloid neoplasm | MNDR-E-MI-62237 |
| MNDR | hsa-miR-590-5p | Prostate cancer | MNDR-E-MI-62238 |
| MNDR | hsa-miR-590-5p | Gastric cancer | MNDR-E-MI-62239 |
| MNDR | hsa-miR-590-5p | Alzheimer disease | MNDR-E-MI-62240 |
| MNDR | hsa-miR-590-5p | Intracranial aneurysm | MNDR-E-MI-62241 |
| MNDR | hsa-miR-590-5p | Esophageal carcinoma | MNDR-E-MI-62242 |
| MNDR | hsa-miR-590-5p | Dysautonomia familial | MNDR-E-MI-62243 |
| MNDR | hsa-miR-590-5p | Polycystic ovary syndrome | MNDR-E-MI-62244 |
| MNDR | hsa-miR-590-5p | Dengue disease | MNDR-E-MI-62245 |
| MNDR | hsa-miR-590-5p | Cardiovascular disease | MNDR-E-MI-62246 |
| MNDR | hsa-miR-590-5p | Parkinson disease | MNDR-E-MI-62247 |
| MNDR | hsa-miR-590-5p | Basal-like breast cancer | MNDR-E-MI-62248 |
| MNDR | hsa-miR-590-5p | Pancreatic cancer | MNDR-E-MI-62249 |
| MNDR | hsa-miR-590-5p | Malignant melanoma | MNDR-E-MI-62250 |
| MNDR | hsa-miR-590-5p | Rectum adenocarcinoma | MNDR-E-MI-62251 |
| MNDR | hsa-miR-590-5p | Nephroblastoma | MNDR-E-MI-62252 |
| MNDR | hsa-miR-590-5p | Colon cancer | MNDR-E-MI-62253 |
| MNDR | hsa-miR-590-5p | Colon adenocarcinoma | MNDR-E-MI-62254 |
| MNDR | hsa-miR-590-5p | West nile virus infection | MNDR-E-MI-62255 |
| MNDR | hsa-miR-590-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-62256 |
| MNDR | hsa-miR-590-5p | Familial ovarian cancer | MNDR-E-MI-62257 |
| MNDR | hsa-miR-590-5p | Prostate adenocarcinoma | MNDR-E-MI-62258 |
| MNDR | hsa-miR-590-5p | Carcinoma ductal breast | MNDR-E-MI-62259 |
| MNDR | hsa-miR-590-5p | Glioma | MNDR-E-MI-62260 |
| MNDR | hsa-miR-590-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-62261 |
| MNDR | hsa-miR-590-5p | Temporal lobe epilepsy | MNDR-E-MI-62262 |
| MNDR | hsa-miR-590-5p | Osteosarcoma | MNDR-E-MI-62263 |
| MNDR | hsa-miR-590-5p | Gastric adenocarcinoma | MNDR-E-MI-62264 |
| MNDR | hsa-miR-590-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-62265 |
| MNDR | hsa-miR-590-5p | Lung squamous cell carcinoma | MNDR-E-MI-62266 |
| MNDR | hsa-miR-590-5p | Lung adenocarcinoma | MNDR-E-MI-62267 |
| MNDR | hsa-miR-590-5p | Thyroid carcinoma | MNDR-E-MI-62268 |
| MNDR | hsa-miR-590-5p | Bladder urothelial carcinoma | MNDR-E-MI-62269 |
| MNDR | hsa-miR-590-5p | Pancreatic adenocarcinoma | MNDR-E-MI-62270 |
| MNDR | hsa-miR-590-5p | Cervical cancer | MNDR-E-MI-62271 |
| MNDR | hsa-miR-590-5p | Carcinoma renal cell | MNDR-E-MI-62272 |
| MNDR | hsa-miR-590-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-62273 |
| MNDR | hsa-miR-590-5p | Clear cell renal cell carcinoma | MNDR-E-MI-62274 |
| MNDR | hsa-miR-590-5p | Stomach carcinoma | MNDR-E-MI-62275 |
| MNDR | hsa-miR-590-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-62276 |
| MNDR | hsa-miR-590-5p | Breast invasive carcinoma | MNDR-E-MI-62277 |
| MNDR | hsa-miR-590-5p | Hepatocellular carcinoma | MNDR-E-MI-62278 |
| MNDR | hsa-miR-590-5p | Familiar ovarian carcinoma | MNDR-E-MI-62279 |
| MNDR | hsa-miR-590-5p | Retinoblastoma | MNDR-E-MI-62280 |
| MNDR | hsa-miR-590-5p | Hodgkin lymphoma | MNDR-E-MI-62281 |
| MNDR | hsa-miR-590-5p | Skin cutaneous melanoma | MNDR-E-MI-62282 |
| MNDR | hsa-miR-590-5p | Skin melanoma | MNDR-E-MI-62283 |
| MNDR | hsa-miR-590-5p | Colorectal cancer | MNDR-E-MI-62284 |
| MNDR | hsa-miR-590-5p | Nasopharynx carcinoma | MNDR-E-MI-62285 |
| MNDR | hsa-miR-590-5p | Multiple myeloma | MNDR-E-MI-62286 |
| MNDR | hsa-miR-590-5p | Uterine cervical neoplasms | MNDR-E-MI-62287 |
| MNDR | hsa-miR-590-5p | Nasopharyngeal cancer | MNDR-E-MI-62288 |
| MNDR | hsa-miR-590-5p | Breast cancer her3+ negative | MNDR-E-MI-62289 |
| MNDR | hsa-miR-590-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-62290 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM9 | Homo sapiens | RR00041200 |
TOP